Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 17, 2023

SELL
$6.09 - $7.93 $6,090 - $7,930
-1,000 Reduced 8.35%
10,976 $68,000
Q3 2022

Oct 26, 2022

SELL
$4.58 - $9.21 $14,491 - $29,140
-3,164 Reduced 20.9%
11,976 $83,000
Q2 2022

Jul 22, 2022

BUY
$7.06 - $23.63 $6,241 - $20,888
884 Added 6.2%
15,140 $127,000
Q1 2022

Apr 22, 2022

SELL
$21.6 - $27.79 $2,008 - $2,584
-93 Reduced 0.65%
14,256 $326,000
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $12,489 - $15,752
543 Added 3.93%
14,349 $396,000
Q3 2021

Nov 05, 2021

BUY
$25.04 - $30.06 $23,011 - $27,625
919 Added 7.13%
13,806 $384,000
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $54,969 - $65,530
2,004 Added 18.41%
12,887 $378,000
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $63,404 - $102,005
-2,967 Reduced 21.42%
10,883 $345,000
Q4 2020

Feb 18, 2021

SELL
$15.31 - $21.12 $2,296 - $3,168
-150 Reduced 1.07%
13,850 $288,000
Q3 2020

Nov 05, 2021

BUY
$14.88 - $20.13 $9,300 - $12,581
625 Added 4.67%
14,000 $218,000
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $298,344 - $403,606
-20,050 Reduced 59.99%
13,375 $208,000
Q2 2020

Nov 16, 2021

BUY
$13.31 - $20.51 $8,318 - $12,818
625 Added 1.91%
33,425 $611,000
Q2 2020

Aug 14, 2020

BUY
$13.31 - $20.51 $15,492 - $23,873
1,164 Added 3.68%
32,800 $600,000
Q1 2020

Nov 05, 2021

BUY
$12.98 - $30.25 $8,112 - $18,906
625 Added 2.02%
31,636 $490,000
Q1 2020

May 15, 2020

BUY
$12.98 - $30.25 $13,693 - $31,913
1,055 Added 3.52%
31,011 $480,000
Q4 2019

Nov 16, 2021

BUY
$18.89 - $31.89 $11,806 - $19,931
625 Added 2.13%
29,956 $896,000
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $554,062 - $935,365
29,331 New
29,331 $877,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.